u/TheVirginVibes · 3d agono track record yet
Joseph Pantginis Reiterates Buy on $BLRX (BiolineRX) as GLIX1 and CheMo4METPANC Advance and APHEXDA Royalties Support Funding Through 1H 2027
H.C. Wainwright analyst reiterates Buy on Bioline RX with $26 price target, citing advancement of first-in-class DDR agent GLIX1 through Phase 1/2a glioblastoma trials, pipeline expansion into additional tumor types, and APHEXDA royalties funding operations through mid-2027.